1.1 MTB Step 3 - Type 2 Diabetes Mellitus Flashcards
Cards Complete:
GENERAL
What are (4) Differences between Diabetes Type 1 & Diabetes Type 2?
DM Type 1:
- Onset = Juvenile
- Body Type = Thin
- DKA = Frequent
- Treatment = Insulin
DM Type 2:
- Onset = Adult
- Body Type = Obese
- DKA = Rare
- Treatment = Lifestyle changes, Oral agents, Insulin
GENERAL
DIAGNOSIS
What are the (4) ways to Diagnose Diabetes Mellitus?
- TWO Fasting Glucose > 125
- ONE Random Glucose > 199 + Symptoms (polyuria, polydipsia, polyphagia)
- Abnormal Glucose Tolerance Test (2hr GTT with 75g Glucose Load)
- HgA1c > 6.5%
GENERAL
SCREENING
What is the Strongest Indication for Screening for Diabetes?
HgA1c > 6.5%
TYPE 2 DM
TREATMENT
What are the (3) Best INITIAL Therapies for Type 2 DM?
Diet
Exercise
Weight Loss
Of patients with Type 2 DM, 25% can be controlled with exercise and weight loss alone.
TYPE 2 DM
TREATMENT
What is the Best INITIAL Medical Therapy for Type 2 DM?
METFORMIN
TYPE 2 DM
TREATMENT
- What is the Mechanism of Action (MOA) for Metformin?
- What are (2) Benefits of Metformin?
- MOA = Blocks Gluconeogenesis
-
Benefits:
- No risk of Hypoglycemia
- No added weight gain because it doesn’t increase the release of endogenous insulin
TYPE 2 DM
TREATMENT
Metformin is Contraindicated for which (2) situations?
- Renal Insufficiency: Metformin may accumulate and increase the risk of Lactic Acidosis.
- Use of Contrast Agents: Contrast may lead to Acute Renal Failure (ARF) and, therefore, to the accumulation of Metformin.
TYPE 2 DM
TREATMENT
What are the names of (3) Sulfonylurea medications used for Type 2 DM?
- Glyburide
- Glimepiride
- Glipizide
TYPE 2 DM
TREATMENT
- What is the Mechanism of Action (MOA) for Sulfonylureas? (e.g., glyburide, glimepiride, glipizide)
- What are (2) Adverse Effects of Sulfonylureas?
- MOA = Increase Release of Insulin from the Pancreas.
-
Adverse Effects:
- Hypoglycemia
- SIADH
TYPE 2 DM
TREATMENT
What are (4) Dipeptidyl Peptidase IV (DPP-IV) Inhibitors used to treat Type 2 DM?
- Sitagliptin
- Linagliptin
- Alogliptin
- Saxagliptin
TYPE 2 DM
TREATMENT
- When can you use Dipeptidyl Peptidase IV (DPP-IV) Inhibitors for treating Type 2 DM?
- (Sitagliptin, Linagliptin, Alogliptin, Saxagliptin)
- What is the Mechanism of Action (MOA) for DPP-IV medications?
- DPP-IV Inhibitors can be added as a second agent to Metformin.
-
MOA:
- Block metabolism of Incretins (e.g., GLP)
- Increase Insulin Release (causes weight gain)
- Block Glucagon
TYPE 2 DM
BASIC SCIENCE CORRELATE
- What are (2) Types of Incretins?
- What is the Mechanism for Incretins?
- Glucagon-Like Peptides (GLPs) & Glucose Insulinotrpic Peptides (GIPs)
-
MOA:
- Increase Insulin Release and Decrease Glucagon Secretion from the Pancreas.
- DPP-IV metabolizes GLP & GIP.
- Inhibiting DPP-IV maintains high levels of GLP & GIP.
TYPE 2 DM
TREATMENT
What are (2) Thiazolidinedione medications used to treat Type 2 DM?
Rosiglitazone
&
Pioglitazone
TYPE 2 DM
TREATMENT
- What is the Mechanism of Action (MOA) for Thiazolidinediones?
- When are Thiazolidinediones contraindicated?
- MOA = Increase peripheral Insulin sensitivity
- Congestive Heart Failure (CHF) - may worsen CHF
TYPE 2 DM
TREATMENT
What are (2) Alpha-Glucosidase Inhibitor medications used to treat Type 2 DM?
Acarbose
&
Miglitol